Skip to main content
FinSpry Logo
FinSpry
PHAR logo
PHAR
(NASDAQ)
Pharming Group N.V.
$13.27-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Pharming Group (PHAR) Stock Price & Financial Analysis

Pharming Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.96 - $13.42
52-Week High$21.34
52-Week Low$9.54
Open$13.27
Volume10.88K
Average Volume (3M)9.85K
Market Cap930.76M
Shares Outstanding70.14M
P/E Ratio (TTM)0.18
Price to Sales (P/S)0.01
Price to Book (P/B)3.46
EV/EBITDA0.16
Revenue (TTM)106.76B
Net Income (TTM)5.31B
Free Cash Flow (TTM)55.40M
EPS (TTM)$77.44
Profit Margin4.97%
Operating Margin1.89%
Return on Equity (ROE)1973.17%
Debt to Equity0.43
50-Day MA$14.10
200-Day MA$15.65
52-Week Change22.94%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Pharming Group

What is the current stock price for PHAR?

As of the latest trading session, PHAR stock trades at $13.27. The 52-week range is $9.54–$21.34, with a day range of $12.96–$13.42.

What is the P/E ratio for PHAR?

Pharming Group's trailing P/E ratio is 0.2, meaning investors pay $0.2 for every $1 of annual earnings. Pharming Group operates in the Healthcare sector.

Does PHAR pay dividends?

Pharming Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PHAR?

Based on 1 analyst, the consensus for PHAR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PHAR?

Pharming Group's market capitalization is $930.8M, classifying it as a small-cap company. Pharming Group operates in the Healthcare sector within the Biotechnology industry.